Publicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (8)

2016

  1. Off-label use of rituximab for systemic lupus erythematosus in Europe

    Lupus Science and Medicine, Vol. 3, Núm. 1

  2. Patterns of drug therapy in newly diagnosed Spanish patients with systemic lupus erythematosus

    Clinical and Experimental Rheumatology, Vol. 34, Núm. 3, pp. 466-472

2014

  1. Influence of psychological stress on headache in patients with systemic lupus erythematosus

    Journal of Rheumatology, Vol. 41, Núm. 3, pp. 453-457

2010

  1. Off-label use of rituximab in 196 patients with severe, refractory systemic autoimmune diseases

    Clinical and Experimental Rheumatology, Vol. 28, Núm. 4, pp. 468-476

2009

  1. STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk

    Annals of the Rheumatic Diseases, Vol. 68, Núm. 11, pp. 1746-1753

2007

  1. Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus

    Arthritis and Rheumatism, Vol. 56, Núm. 4, pp. 1234-1241

2006

  1. Registrolesaf. Características de los pacientes con lupus eritematoso sistémico síndrome antifosfolipídico registrados por usuarios médicos especialistas en reumatología y medicina interna

    Reumatologia Clinica, Vol. 2, Núm. 3, pp. 131-136

2004

  1. Intolerancia a la hidroxicloroquina comercializada en España (Dolquine®) en pacientes con patología autoinmune

    Revista Clinica Espanola, Vol. 204, Núm. 11, pp. 588-591